(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) and stenting, ...
Sep 19, 2014
0
0
The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...
Sep 16, 2014
0
0
Ambulance administration of the antiplatelet medication ticagrelor to patients with a type of heart attack known as ST segment elevation myocardial infarction (STEMI) is not better than hospital administration, in terms of ...
Sep 1, 2014
0
0
Bivalirudin and heparin are two anticoagulant options for patients undergoing coronary stenting for ischemic heart disease. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but ...
Aug 15, 2014
0
0
Research conducted by University of Twente PhD candidate Kenneth Tandjung has shown that the new generation of drug-eluting stents, which is being used in coronary angioplasty to open narrowed coronary arteries, is safe and ...
Jul 15, 2014
0
0
Tiny metal tubes called stents - which keep blood flowing through diseased coronary arteries by slowly releasing medication - have helped to save the lives of millions at risk of heart disease. Once inserted into arteries ...
Jun 5, 2014
0
0
If you've just received a coronary artery stent to prop open a blood vessel, your life may depend on filling your prescription and taking an anti-clotting drug within days of leaving the hospital, according to a large study ...
May 28, 2014
0
0
A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of stent thrombosis (ST) in patients undergoing percutaneous coronary intervention (PCI). Results of the study were released today ...
Mar 27, 2014
0
0
The interventional cardiology team led by Ehtisham Mahmud, MD, FACC, at UC San Diego Sulpizio Cardiovascular Center (SCVC) has successfully completed the first two robotically-assisted coronary angioplasty/stent procedures ...
Dec 23, 2013
0
0
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...
Oct 30, 2013
0
0
